Skip to main content
Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences 6/2010

01.11.2010 | Original article

Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function

verfasst von: Atsushi Nanashima, Syuuichi Tobinaga, Takafumi Abo, Takashi Nonaka, Hiroaki Takeshita, Shigekazu Hidaka, Terumitsu Sawai, Takeshi Nagayasu

Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background/purpose

To prevent or reduce hepatic complications after hepatectomy, it is important to employ preoperative predictive parameters and to determine the indications for hepatectomy. In the present study, we evaluated risk parameters in patients who underwent hepatectomy between 1994 and 2003, and selected three parameters to modify the surgical indications. Using these indications before surgery in patients who underwent hepatectomy between 2004 and 2008, we compared the prevalences of postoperative complications in the the two groups of patients.

Methods

We examined 250 consecutive patients who underwent hepatectomy for liver disease [149 in 1994–2003 (termed the early period) and 101 in 2004 to 2008 (termed the later period)].

Results

In the early period, uncontrolled ascites was observed in 55 patients and hepatic failure was observed in 15 of the 149 patients. Multivariate analysis identified volume of the resected liver (≥50%), intraoperative blood loss (≥1500 ml), prothrombin activity (<70%), hyaluronic acid level (≥200 ng/ml), and LHL15 (hepatic uptake ratio of technetium-99m galactosyl human serum albumin (99mTc-GSA) (<0.85) as risk factors; the latter three parameters were evaluated as predictors of outcome. From 2004, we used these three parameters, in addition to the indocyanine green retention rate at 15 min (ICGR15), as criteria for indications for hepatectomy. Despite the lower prevalence of normal liver in the later period, comparisons showed decreases in the rates of uncontrolled ascites (23 vs. 37%, P = 0.03), hepatic failure (4 vs. 10%, P = 0.12), and hepatic complications (25 vs. 44%, P = 0.003) in patients in the later period compared with these rates in the previous period.

Conclusions

The use of prothrombin activity, and levels of hyaluronic acid and LHL15, as parameters of functional liver reserve in the selection of candidates for surgery reduced the incidence of hepatic complications after hepatectomy.
Literatur
1.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708.PubMed Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708.PubMed
2.
Zurück zum Zitat Fan T, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229:322–30.CrossRefPubMed Fan T, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229:322–30.CrossRefPubMed
3.
Zurück zum Zitat Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589–94.CrossRefPubMed Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589–94.CrossRefPubMed
4.
Zurück zum Zitat Capussotti L, Viganò L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G. Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg. 2008;96:88–94.CrossRef Capussotti L, Viganò L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G. Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg. 2008;96:88–94.CrossRef
5.
Zurück zum Zitat Nanashima A, Yamaguchi H, Shibasaki S, Morino S, Ide N, Takeshita H, et al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: clinical evaluation and patient outcome. Hepatol Res. 2004;28:184–90.CrossRefPubMed Nanashima A, Yamaguchi H, Shibasaki S, Morino S, Ide N, Takeshita H, et al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: clinical evaluation and patient outcome. Hepatol Res. 2004;28:184–90.CrossRefPubMed
6.
Zurück zum Zitat Nanashima A, Yamaguchi H, Tanaka K, Shibasaki S, Tsuji T, Ide N, et al. Preoperative serum hyaluronic acid level as a good predictor of posthepatectomy complications. Surg Today. 2004;34:913–9.CrossRefPubMed Nanashima A, Yamaguchi H, Tanaka K, Shibasaki S, Tsuji T, Ide N, et al. Preoperative serum hyaluronic acid level as a good predictor of posthepatectomy complications. Surg Today. 2004;34:913–9.CrossRefPubMed
7.
Zurück zum Zitat Nanashima A, Yamaguchi H, Morino S, Ide N, Takeshita H, Tsuji T, et al. Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study. Dig Dis Sci. 2006;51:1190–5.CrossRefPubMed Nanashima A, Yamaguchi H, Morino S, Ide N, Takeshita H, Tsuji T, et al. Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study. Dig Dis Sci. 2006;51:1190–5.CrossRefPubMed
8.
Zurück zum Zitat Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163:515–8.CrossRefPubMed Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163:515–8.CrossRefPubMed
9.
Zurück zum Zitat Ishigami Y, Masuzawa M, Miyoshi E, Kato M, Tamura K, Kanda M, et al. Clinical applications of ICG finger monitor in patients with liver disease. J Hepatol. 1993;19:232–40.CrossRefPubMed Ishigami Y, Masuzawa M, Miyoshi E, Kato M, Tamura K, Kanda M, et al. Clinical applications of ICG finger monitor in patients with liver disease. J Hepatol. 1993;19:232–40.CrossRefPubMed
10.
Zurück zum Zitat Mitsumori A, Nagaya I, Kimoto S, Akaki S, Togami I, Takeda Y, et al. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med. 1998;25:1377–82.CrossRefPubMed Mitsumori A, Nagaya I, Kimoto S, Akaki S, Togami I, Takeda Y, et al. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med. 1998;25:1377–82.CrossRefPubMed
11.
Zurück zum Zitat Liver Cancer Study Group of Japan. Clinical and laboratory findings. In: Makuuchi M, editor. General rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara & Co; 2003. p 13–28. Liver Cancer Study Group of Japan. Clinical and laboratory findings. In: Makuuchi M, editor. General rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara & Co; 2003. p 13–28.
12.
Zurück zum Zitat Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431–5.CrossRefPubMed Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431–5.CrossRefPubMed
13.
Zurück zum Zitat Takasaki T, Kobayashi S, Suzuki S, Muto H, Marada M, Yamana Y, et al. Predetermining postoperative hepatic function for hepatectomies. Int Surg. 1980;65:309–13.PubMed Takasaki T, Kobayashi S, Suzuki S, Muto H, Marada M, Yamana Y, et al. Predetermining postoperative hepatic function for hepatectomies. Int Surg. 1980;65:309–13.PubMed
14.
Zurück zum Zitat Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resection surgery for hepatic tumors. Hepatology. 1997;26:1176–81.PubMed Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resection surgery for hepatic tumors. Hepatology. 1997;26:1176–81.PubMed
15.
Zurück zum Zitat Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7.PubMed Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7.PubMed
16.
Zurück zum Zitat Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304–9.CrossRefPubMed Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304–9.CrossRefPubMed
17.
Zurück zum Zitat Yanaga K, Honda H, Ikeda Y, Nishizaki AT, Yamamoto K, Sugimachi K. Significance of liver size in hepatic surgery. HPB Surg. 1997;10:195–9.CrossRefPubMed Yanaga K, Honda H, Ikeda Y, Nishizaki AT, Yamamoto K, Sugimachi K. Significance of liver size in hepatic surgery. HPB Surg. 1997;10:195–9.CrossRefPubMed
18.
Zurück zum Zitat Greenburg AG. Benefits and risks of blood transfusion in surgical patients. World J Surg. 1996;20:1189–93.CrossRefPubMed Greenburg AG. Benefits and risks of blood transfusion in surgical patients. World J Surg. 1996;20:1189–93.CrossRefPubMed
19.
Zurück zum Zitat Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–8.CrossRefPubMed Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–8.CrossRefPubMed
20.
Zurück zum Zitat Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child–Turcotte–Pugh classification in predicting outcome. Arch Surg. 2005;140:650–4.CrossRefPubMed Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child–Turcotte–Pugh classification in predicting outcome. Arch Surg. 2005;140:650–4.CrossRefPubMed
21.
Zurück zum Zitat Eguchi S, Kamlot A, Ljubimova J, Hewitt WR, Lebow LT, Demetriou AA, et al. Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration. Hepatology. 1996;24:1452–9.CrossRefPubMed Eguchi S, Kamlot A, Ljubimova J, Hewitt WR, Lebow LT, Demetriou AA, et al. Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration. Hepatology. 1996;24:1452–9.CrossRefPubMed
22.
Zurück zum Zitat Itasaka H, Suehiro T, Wakiyama S, Yanaga K, Shimada M, Sugimachi K. Significance of hyaluronic acid for evaluation of hepatic endothelial cell damage after cold preservation/reperfusion. J Surg Res. 1995;59:589–95.CrossRefPubMed Itasaka H, Suehiro T, Wakiyama S, Yanaga K, Shimada M, Sugimachi K. Significance of hyaluronic acid for evaluation of hepatic endothelial cell damage after cold preservation/reperfusion. J Surg Res. 1995;59:589–95.CrossRefPubMed
23.
Zurück zum Zitat Yachida S, Wakabayashi H, Kokudo Y, Goda F, Okada S, Maeba T, et al. Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg. 2000;24:359–64.CrossRefPubMed Yachida S, Wakabayashi H, Kokudo Y, Goda F, Okada S, Maeba T, et al. Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg. 2000;24:359–64.CrossRefPubMed
24.
Zurück zum Zitat Das BC, Isaji S, Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg. 2001;25:266–72.CrossRefPubMed Das BC, Isaji S, Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg. 2001;25:266–72.CrossRefPubMed
25.
Zurück zum Zitat Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426–9.CrossRefPubMed Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426–9.CrossRefPubMed
26.
Zurück zum Zitat Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355–73.CrossRefPubMed Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355–73.CrossRefPubMed
27.
Zurück zum Zitat Kawamura H, Kamiyama T, Nakagawa T, Nakanishi K, Yokoo H, Tahara M, et al. Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy. J Gastroenterol Hepatol. 2008;23:1235–41.CrossRefPubMed Kawamura H, Kamiyama T, Nakagawa T, Nakanishi K, Yokoo H, Tahara M, et al. Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy. J Gastroenterol Hepatol. 2008;23:1235–41.CrossRefPubMed
28.
Zurück zum Zitat Fukui A, Murase K, Tsuda T, Fujii T, Ikezoe J. Assessment of liver function in chronic liver diseases and regional function of irradiated liver by means of 99mTc-galactosyl-human serum albumin liver scintigraphy and quantitative spectral analysis. Ann Nucl Med. 2000;14:467–76.CrossRefPubMed Fukui A, Murase K, Tsuda T, Fujii T, Ikezoe J. Assessment of liver function in chronic liver diseases and regional function of irradiated liver by means of 99mTc-galactosyl-human serum albumin liver scintigraphy and quantitative spectral analysis. Ann Nucl Med. 2000;14:467–76.CrossRefPubMed
29.
Zurück zum Zitat Yamanaka N, Okamoto E, Kuwata K, Tanaka N. A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg. 1984;200:658–63.CrossRefPubMed Yamanaka N, Okamoto E, Kuwata K, Tanaka N. A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg. 1984;200:658–63.CrossRefPubMed
30.
Zurück zum Zitat Uchiyama K, Mori K, Tabuse K, Ueno M, Ozawa S, Nakase T, et al. Assessment of liver function for successful hepatectomy in patients with hepatocellular carcinoma with impaired hepatic function. J Hepatobiliary Pancreat Surg. 2008;15:596–602.CrossRefPubMed Uchiyama K, Mori K, Tabuse K, Ueno M, Ozawa S, Nakase T, et al. Assessment of liver function for successful hepatectomy in patients with hepatocellular carcinoma with impaired hepatic function. J Hepatobiliary Pancreat Surg. 2008;15:596–602.CrossRefPubMed
31.
Zurück zum Zitat Nagino M, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Sasaki R, et al. Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract. World J Surg. 1993;17:250–5.CrossRefPubMed Nagino M, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Sasaki R, et al. Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract. World J Surg. 1993;17:250–5.CrossRefPubMed
32.
Zurück zum Zitat Togo S, Matsuo K, Tanaka K, Matsumoto C, Shimizu T, Ueda M, et al. Perioperative infection control and its effectiveness in hepatectomy patients. J Gastroenterol Hepatol. 2007;22:1942–8.CrossRefPubMed Togo S, Matsuo K, Tanaka K, Matsumoto C, Shimizu T, Ueda M, et al. Perioperative infection control and its effectiveness in hepatectomy patients. J Gastroenterol Hepatol. 2007;22:1942–8.CrossRefPubMed
33.
Zurück zum Zitat Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y, et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg. 2009;144:46–51.CrossRefPubMed Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y, et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg. 2009;144:46–51.CrossRefPubMed
Metadaten
Titel
Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function
verfasst von
Atsushi Nanashima
Syuuichi Tobinaga
Takafumi Abo
Takashi Nonaka
Hiroaki Takeshita
Shigekazu Hidaka
Terumitsu Sawai
Takeshi Nagayasu
Publikationsdatum
01.11.2010
Verlag
Springer Japan
Erschienen in
Journal of Hepato-Biliary-Pancreatic Sciences / Ausgabe 6/2010
Print ISSN: 1868-6974
Elektronische ISSN: 1868-6982
DOI
https://doi.org/10.1007/s00534-010-0281-5

Weitere Artikel der Ausgabe 6/2010

Journal of Hepato-Biliary-Pancreatic Sciences 6/2010 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.